Literature DB >> 324407

Controlled trial of antenatal barbiturates in rhesus haemolytic disease.

S H Towers, G P McMullin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 324407      PMCID: PMC1544686          DOI: 10.1136/adc.52.4.324

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  6 in total

1.  Phototherapy in newborn infants with severe rhesus hemolytic disease.

Authors:  J Moller; F Ebbesen
Journal:  J Pediatr       Date:  1975-01       Impact factor: 4.406

2.  Spectrophotometric measurement of bilirubin concentrations in the serum of the newborn by the use of a microcapillary method.

Authors:  D WHITE; G A HAIDAR; J G REINHOLD
Journal:  Clin Chem       Date:  1958-06       Impact factor: 8.327

3.  Decrease of total serum-bilirubin concentration in newborn infants after phenobarbitone treatment.

Authors:  D Trolle
Journal:  Lancet       Date:  1968-09-28       Impact factor: 79.321

4.  Controlled trials of phenobarbitone therapy of neonatal jaundice.

Authors:  C Ramboer; R P Thompson; R Williams
Journal:  Lancet       Date:  1969-05-10       Impact factor: 79.321

5.  Phenobarbitone and the neonate.

Authors:  J T Wilson
Journal:  Lancet       Date:  1969-07-26       Impact factor: 79.321

6.  Phenobarbitone in rhesus haemolytic disease. A controlled trial.

Authors:  G P McMullin; M F Hayes; S C Arora
Journal:  Lancet       Date:  1970-11-07       Impact factor: 79.321

  6 in total
  1 in total

Review 1.  Antenatal phenobarbital for reducing neonatal jaundice after red cell isoimmunization.

Authors:  J T Thomas; P Muller; C Wilkinson
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.